Epigenetic clocks—tools designed to measure biological age through DNA methylation—capture distinct, non-overlapping biological processes rather than a single universal aging mechanism. According to a study published in npj Aging, researchers have developed Transcriptomic Aging Gene Scores (TAGS) to better interpret these clocks, showing that gene expression patterns often predict health outcomes like mortality and frailty more accurately than traditional methylation-based measures alone.
Moving Beyond Chronological Age
Chronological age is a poor predictor of individual health trajectories. Researchers have long turned to epigenetic clocks to understand why two people of the same birth year can have vastly different physiological profiles. These clocks analyze DNA methylation (DNAm)—chemical modifications to DNA that influence gene activity. However, the exact biological pathways “ticking” inside these clocks have remained largely opaque.
In the study led by T.E. Arpawong and colleagues, investigators analyzed data from the Health and Retirement Study (HRS) Venous Blood Study. By examining 3,227 participants with both DNAm and RNA-seq data, the team identified the specific gene expression signatures linked to five prominent clocks: Horvath, Hannum, PhenoAge, GrimAge, and DunedinPACE.
Did you know?
The study found that the number of differentially expressed genes (DEGs) did not correlate with the number of CpG sites in a clock. For instance, the Horvath clock showed only 49 DEGs, while the DunedinPACE clock was associated with 3,204, proving that larger clocks do not necessarily capture more complex gene-expression changes.
Distinct Biological Pathways for Different Clocks
The research revealed that no single biological pathway is common to all five clocks. Instead, each clock functions as a specialized sensor for different types of cellular degradation. The study identified specific functional associations for each:
- Horvath Clock: Linked to metabolism and signal transduction.
- Hannum Clock: Associated with homeostasis and vascular wall processes.
- PhenoAge: Primarily tied to cellular senescence pathways.
- GrimAge: Connected to interferon signaling.
- DunedinPACE: Linked to a broad range of processes, including protein metabolism, nervous system development, and cellular respiration.
While individual pathways varied, broader Gene Ontology (GO) analysis identified four shared functional themes: metabolic processes, developmental processes, immune system functions, and regulatory signaling. This suggests that while the clocks are distinct, they are all scanning different facets of the same overarching aging architecture.
The Role of Transcriptomic Aging Gene Scores (TAGS)
To improve clinical utility, the researchers developed TAGS, which translate the gene expression signatures identified in the study into actionable scores. When tested against health outcomes in a hold-out dataset, TAGS often outperformed the parent epigenetic clocks.
The study reported that TAGS showed stronger associations with mortality, frailty, activities of daily living (ADLs), walking speed, diabetes, and lung function. Because these scores are derived from RNA-seq data, they provide a more direct look at the functional state of the body’s cells than DNA methylation alone. However, the authors noted that these findings require validation in more diverse, independent populations, as the current cohort consisted primarily of White older adults.
Frequently Asked Questions
What is an epigenetic clock?
An epigenetic clock is a mathematical model that uses DNA methylation levels at specific sites in the genome to estimate an individual’s biological age, which may differ from their chronological age.
Why are different clocks needed?
As the npj Aging study highlights, different clocks capture different biological processes. For example, some are better at predicting immune-related decline, while others are more sensitive to metabolic or cellular senescence pathways.
Can these clocks predict specific diseases?
Yes, the study found that transcriptomic scores (TAGS) were significantly associated with health outcomes such as heart disease, diabetes, and physical frailty, often providing a more precise risk profile than standard epigenetic clocks.
Is this technology ready for clinical use?
Not yet. Researchers emphasize that while TAGS are promising, they require further validation in larger, more diverse populations before they can be used in routine clinical settings.
Are you interested in the future of longevity science? Subscribe to our newsletter for the latest updates on multi-omics research and biological aging, or explore our archive of studies on healthy aging.
Related reading